微生物来源的HLE抑制剂N01WA-735E的研究

人白细胞弹性蛋白酶抑制剂为筛选炎症和癌症的重要靶点。应用白细胞弹性蛋白酶抑制剂高通量的筛选模型对数千株放线菌进行筛选,发现了阳性菌株N01 WA-735。首先通过形态学和化学分类学鉴定其为链霉菌属。采用有机溶剂提取、硅胶柱色谱、Sephadex LH-20柱色谱和结晶等方法对该菌株的发酵产物进行了分离纯化,得到活性单体化合物N01 WA-735E,通过对N01 WA-735E的理化性质和波谱数据分析,确定其结构与文献报道的化合物BE-52440A相同。该化合物对人白细胞弹性蛋白酶有很强的抑制活性,其IC50为3.02μmol/L。该化合物对人白细胞弹性蛋白酶的抑制活性国内外未见报道。     

微生物来源的酶抑制剂研究进展

１９５８年,植物学家Ｋｏｈｌａｎｄ首先提出次生代谢的概念,１９６０年Ｂｕ’Ｌｏｃｋ把这一概念引进微生物学领域。微生物次生代谢物包括抗生素、色素、毒素、信息素、动植物生长促进剂和生物药物素（ｂｉｏｐｈａｒｍａｃｅｕｔｉｎ）等。其中生物药物素包括酶抑制...     

微生物来源的纤溶活性酶研究进展

微生物是溶栓药物的重要来源。到目前为止,已发现可产生纤溶活性酶的微生物主要有：β-溶血性链球菌、金黄色葡萄球菌、芽孢杆菌属的多种细菌、海洋假单胞菌、链霉菌及真菌。本文就微生物产生纤溶活性酶的来源、理化性质、作用机制、基因结构与改造、临床应用等方面进行了综述。     

放线菌制剂对人参生长及根域土壤微生物区系的影响

以小兴安岭地区人参为研究对象,探索放线菌制剂对人参的促生效应及对人参根区、根表土壤微生物区系的影响.结果表明： 经放线菌制剂Streptomyces pactum（Act12）处理后,人参药用部分产量增加,品质改善;叶片诱导酶活性提高,根系活力增强;土壤中细菌、放线菌的数量和比例显著增加,真菌的数量和比例减少.与对照相比,土壤微生物区系结构改变:优势菌荧光假单胞菌、韩国假单胞菌和氧化微杆菌在根区、根表土壤中的数量大幅提高;病原真菌烟色织孢霉在根区土壤中减少,在根表土壤中消失.表明施用放线菌制剂Act12能够改善土壤微生物区系,提高人参植株的抗性和根系活力,增加产量并改善品质.     

米修链霉菌TF78对香蕉枯萎病的田间防效及根际土壤微生物的影响

【背景】香蕉枯萎病是香蕉生产上的毁灭性病害,生物防治是遏制该病害发生的有效手段。在前期的研究中,从健康香蕉根际土壤中分离获得一株对香蕉枯萎病具有良好盆栽防治效果的生防菌——米修链霉菌(Streptomyces misionensis) TF78,但其对香蕉枯萎病的田间生防潜力和对土壤微生物环境的影响尚不清楚。【目的】评价米修链霉菌TF78对香蕉枯萎病的田间防治效果,明确其对香蕉根际土壤微生物群落的影响。【方法】选取两块发病香蕉园,测定该生防菌株对香蕉枯萎病的防治效果,并利用扩增子测序技术分析施用菌剂组和空白对照组共12份香蕉根际土壤的微生物多样性和丰度。【结果】米修链霉菌TF78对两块香蕉园的田间防效分别达55.30%和45.32%。该生防菌株处理组的物种稀释曲线坡度大于空白对照组,并显著富集了优势种群梳霉门(Kickxellomycota),消减了绿弯菌门(Chloroflexi)、酸杆菌门(Acidobacteria)和苔藓杆菌(Bryobacter)的丰度,对土壤中优势种群变形菌门(Proteobacteria)、厚壁菌门(Firmicutes)、放线菌门(Actinobacteria)、芽单胞菌门(Gemmatimonadetes)及木霉属(Trichoderma)、鞘氨醇单胞菌属(Sphingomonas)、寡养单胞菌属(Stenotrophomonas)和芽孢杆菌属(Bacillus)的相对丰度影响不显著。【结论】米修链霉菌TF78塑造了不利于香蕉枯萎病菌Fusarium oxysporum f.sp.cubense存活的土壤环境,有效降低了田间香蕉枯萎病的发生,同时对土壤中大部分具有重要生态功能和抑菌功能的优势微生物种群影响不显著。该研究结果为米修链霉菌TF78的进一步开发应用奠定了基础。     

微生物来源的二氢乳清酸脱氢酶抑制剂F01WB-1315A，B

摘要：目的 从微生物次生代谢产物中筛选免疫相关疾病治疗药物重要靶点—－二氢乳清酸脱氢酶的抑制剂。方法 利用自建的快速、高效的二氢乳清酸脱氢酶抑制剂的高通量筛选方法,从4560株真菌菌株中筛选阳性菌株。阳性菌株的发酵产物进行分离纯化获得活性化合物,再通过对活性化合物的紫外、质谱、核磁等理化数据的分析进行结构鉴定。结果 筛选分离得到2个活性化合物F01WB-1315A和F01WB-1315B。F01WB-1315A对二氢乳清酸脱氢酶有强的抑制活性,IC50=0.07 μg/mL,于20 μg/mL浓度下对体外     

一株新的α-糖苷酶抑制剂生产菌株PW0852的初步研究

从土壤中分离并筛选得到了一株α-糖苷酶抑制剂生产菌PW0852。根据形态特征、培养特征、生理生化特征及16S rRNA序列相似性分析等多相分类方法, 初步判定菌株PW0852为淡紫灰链霉菌(Streptomyces lavendulae)。该菌经10 L发酵罐水平发酵, 发酵液中可积累一定量的α-糖苷酶抑制剂。采用膜过滤技术、离子交换树脂吸附及冷冻干燥等方法, 从PW0852发酵液中分离获得混合型α-糖苷酶抑制剂GIB852。GIB852对人类胰腺α-淀粉酶和α-麦芽糖酶都有明显的抑制作用, 其对麦芽糖酶的抑制性比同剂量的市售双糖酶抑制剂米格列醇强28.7倍, 而对α-淀粉酶的抑制性较弱。通过小鼠糖耐量实验, 发现α-糖苷酶抑制剂GIB852对哺乳动物餐后高血糖的形成有明显改善作用, 具有开发为糖尿病药物的潜力。     

链霉菌来源的UDP_葡萄糖_4_差向异构酶基因的克隆表达及酶性质研究

经同源性比较,链霉菌139（Streptomyces sp.139）产生胞外多糖依博素的生物合成基因簇中ste19 基因编码的蛋白Ste19与UDP_葡萄糖_4_差向异构酶有较高同源性。将ste19 基因克隆至质粒pET30a,在大肠杆菌BL21(DE3)中进行了异源表达。产生的可溶性Ste19重组蛋白,占细胞总蛋白的26%,说明该基因高GC含量（73.8%）及第三位碱基偏向使用GC(96.2%)并未影响其高效表达。SDS_PAGE结果显示重组蛋白的分子量约37kD,与理论推测值基本相同。经亲和层析纯化后得到了较高纯度的重组蛋白,经HPLC分析纯度为92.9%。酶活性分析表明：Ste19蛋白可将UDP_葡萄糖转化为UDP_半乳糖,因此,Ste19蛋白是UDP_葡萄糖_4_差向异构酶,它可能参与了依博素的生物合成。     

链霉菌来源的UDP-葡萄糖-4-差向异构酶基因的克隆表达及酶性质研究

经同源性比较,链霉菌139(Streptomycessp.139)产生胞外多糖依博素的生物合成基因簇中ste19基因编码的蛋白Ste19与UDP_葡萄糖_4_差向异构酶有较高同源性。将ste19基因克隆至质粒pET30a,在大肠杆菌BL21(DE3)中进行了异源表达。产生的可溶性Ste19重组蛋白,占细胞总蛋白的26%,说明该基因高GC含量(73.8%)及第三位碱基偏向使用GC(96.2%)并未影响其高效表达。SDS_PAGE结果显示重组蛋白的分子量约37kD,与理论推测值基本相同。经亲和层析纯化后得到了较高纯度的重组蛋白,经HPLC分析纯度为92.9%。酶活性分析表明:Ste19蛋白可将UDP_葡萄糖转化为UDP_半乳糖,因此,Ste19蛋白是UDP_葡萄糖_4_差向异构酶,它可能参与了依博素的生物合成。     

Streptomyces rochei D74菌剂对向日葵、列当及其根际微生物的影响北大核心

【目的】研究娄彻氏链霉菌(Streptomyces rochei)D74菌剂促进向日葵生长和抑制列当寄生的作用,及其对根际微生物的影响。【方法】通过构建向日葵-列当-S.rochei D74共培养体系,观察D74菌株对列当寄生的影响;采用田间小区试验,测定D74菌剂接种对向日葵植物生理指标和列当出土数的影响;测定向日葵产量指标,研究D74菌剂对向日葵籽粒品质及产量的影响;利用16S rRNA基因高通量测序技术和传统微生物培养方法,分析添加D74菌剂对向日葵根际微生物群落结构的影响。【结果】D74菌剂能够促进向日葵生长[茎秆重和花盘重分别显著增加(P<0.05)37%-40%和21%-37%],同时抑制28%-46%(P<0.05)的列当出土;还可以提高向日葵籽粒中粗蛋白含量5%-9%、大粒占比约66%(P<0.05)和百粒重8%-18%,并且通过产量测定表明,D74菌剂可增产约30%(P<0.05),这对提高农民经济收益具有深远意义。D74菌剂对向日葵根际微生物群落具有显著影响,调节了群落有益微生物数量。【结论】D74菌剂可以显著降低向日葵根部列当寄生病害的发生,促进花盘生长,使籽粒饱满,具有实际应用价值和推广意义。     

Binding of the Bovine and Porcine Pancreatic Secretory Trypsin Inhibitor (Kazal) To Human Leukocyte Elastase: A Thermodynamic Study

Abstract

The effect of pH and temperature on the apparent association equilibrium constant (K_a) for the binding of the bovine and porcine pancreatic secretory trypsin inhibitor (Kazal-type inhibitor, PSTI) to human leukocyte elastase has been investigated. At pH8.0, values of the apparent thermodynamic parameters for human leukocyte elastase: Kazal-type inhibitor complex formation are: bovine PSTT – K_a = 6.3 × 10⁴M^?1, δ5G° = -26.9kJ/mol, δH° = +11.7kJ/mol, and δS° = +1.3 × 10² entropy units; porcine PSTI –K_a = 7.0 × 10³M^?1,δG° = -21.5kJ/mol, δH° = +13.0kJ/mol, and δS° = +1.2 × 10² entropy units (values of K_a δG° and δS° were obtained at 21.0°C; values of δH° were temperature independent over the range (between 5.0°C and 45.0°C) explored). On increasing the pH from 4.5 to 9.5, values of K_a for bovine and porcine PSTI binding to human leukocyte elastase increase thus reflecting the acidic pK-shift of the His57 catalytic residue from ?7.0, in the free enzyme, to ?5.1, in the serine proteinase: inhibitor complexes. Thermodynamics of bovine and porcine PSTI binding to human leukocyte elastase has been analyzed in parallel with that of related serine (pro)enzyme/Kazal-type inhibitor systems. Considering the known molecular models, the observed binding behaviour of bovine and porcine PSTI to human leukocyte elastase was related to the inferred stereochemistry of the serine proteinase/inhibitor contact region(s).     

Letter to the Editor: 1H, 15N and 13C NMR Resonance Assignments of Staphostatin A, a Specific Staphylococcus Aureus Cysteine Proteinase Inhibitor

The increasing antibiotic resistance of an important human pathogen Staphylococcus aureus calls for the development of new therapeutic strategies. Staphylococcal cysteine proteases have been suggested as targets for such therapies. The recent discovery of staphostatins, specific protein inhibitors of these enzymes, gives prospects for the design and production of synthetic, low molecular weight analogs which might become drugs. We have decided to structurally characterize staphostatin A, a representative inhibitor of staphylococcal cysteine proteases, and to assess its binding mode to the target protease with the view of clarifying the specificity determinants. Here we report the (1)H, (15)N and (13)C NMR resonance assignments of staphostatin A.     

Cloning and expression of a tylosin resistance gene from a tylosin-producing strain of Streptomyces fradiae

Summary A gene conferring high-level resistance to tylosin in Streptomyces lividans and Streptomyces griseofuscus was cloned from a tylosin-producing strain of Streptomyces fradiae. The tylosin-resistance (Tyl^r) gene (tlrA) was isolated on five overlapping DNA fragments which contained a common 2.6 Kb KpnI fragment. The KpnI fragment contained all of the information required for the expression of the Tyl^r phenotype in S. lividans and S. griseofuscus. Southern hybridization indicated that the sequence conferring tylosin resistance was present on the same 5 kb SalI fragment in genomic DNA from S. fradiae and several tylosin-sensitive (Tyl^s) mutants. The cloned tlrA gene failed to restore tylosin resistance in two Tyl^s mutants derived by protoplast formation and regeneration, and it restored partial resistance in a Tyl^s mutant obtained by N-methyl-N-nitro-N-nitrosoguanidine (MNNG) mutagenesis. The tlrA gene conferred resistance to tylosin, carbomycin, niddamycin, vernamycin-B and, to some degree, lincomycin in S. griseofuscus, but it had no effect on sensitivity to streptomycin or spectinomycin, suggesting that the cloned gene is an MLS (macrolide, lincosamide, streptogramin-B)-resistance gene. Twenty-eight kb of S. fradiae DNA surrounding the tlrA gene was isolated from a genomic library in bacteriophage Charon 4. Introduction of these DNA sequence into S. fradiae mutants blocked at different steps in tylosin biosynthesis failed to restore tylosin production, suggesting that the cloned Tyl^r gene is not closely linked to tylosin biosynthetic genes.     

新型蛋白酶体抑制剂YSY-01A对肿瘤细胞促血管生成作用的抑制及其机制初探

YSY-01A是一种新型蛋白酶体抑制剂,前期研究已经证实其对肿瘤细胞的增殖有抑制作用．但是它对肿瘤血管生成是否有影响尚不明确．本研究旨在探明YSY-01A阻碍肿瘤细胞促进血管生成的作用及机制．我们首先将磺酰罗丹明B(sulforhodamine B,SRB)法与细胞共培养(Transwell)模型相结合,探讨YSY-01A抑制人结肠癌细胞(HT-29 cells)对人脐静脉内皮细胞(human umbilical vein endothelial cells,HUVECs)的增殖促进作用;运用高内涵筛选(high content screening,HCS)法研究YSY-01A对HT-29细胞中NF-κB核转位的影响;利用Western blot法检测YSY-01A对HT-29细胞中缺氧诱导因子-1α(hypoxia- inducible factor-1α,HIF-1α)及血管内皮生长因子(vascular endothelial growth factor,VEGF)的表达调控．为了观察YSY-01A对HUVEC增殖和运动有无直接抑制作用,我们采用SRB法观察YSY-01A对HUVEC的增殖抑制作用;运用HCS法分别考察YSY-01A对HUVEC的运动抑制和细胞毒作用．结果证实,YSY-01A可以阻碍HT-29细胞对HUVEC的增殖促进作用并具有浓度依赖性．YSY-01A还可抑制HT-29细胞中NF-κB的核转位,下调HIF-1α及VEGF的表达．进一步研究证实,YSY-01A能够浓度依赖地抑制HUVECs的增殖和运动,而不伴有明显的细胞毒作用．上述结果表明,YSY-01A可以通过抑制蛋白酶体活性下调肿瘤细胞中促血管生成因子的表达,进而在血管内皮细胞中发挥抗血管生成作用．     

Trypsin Inhibitor from Poecilanthe parviflora Seeds: Purification, Characterization, and Activity Against Pest Proteases

Plants synthesize a variety of molecules, including proteinaceous proteinase inhibitors, to defend themselves of being attacked by insects. In this work, a novel trypsin inhibitor (PPTI) was purified from the seeds of the native Brazilian tree Poecilanthe parviflora (Benth) (Papilioinodeae, Leguminosae) by gel filtration chromatography on a Sephadex G-100 followed by Superdex G75 chromatography (FPLC), Sepharose 4B-Trypsin column, and fractionated by reversed-phase HPLC on a C-18 column. SDS-PAGE showed that PPTI consisted of a single polypeptide chain with molecular mass of about 16 kDa. The dissociation constant of 1.0 x 10(-7) M was obtained with bovine trypsin. PPTI was stable over a wide range of temperature and pH and in the presence of DTT. The N-terminal sequence of the PPTI showed a high degree of homology with other Kunitz-type inhibitors. Trypsin-like activity in midguts of larval Diatraea saccharalis, Anagasta kuehniella, Spodoptera frugiperda, and Corcyra cephalonica were substantially inhibited by PPTI.     

Isolation and Properties of a New Kallikrein Inhibitor from Tityus serrulatus Venom

The kallikrein inhibitor-peptide content of Tityus serrulatus scorpion crude venom was purified by Sephadex G-50 and Sephadex G-25 fine gel filtration chromatographies, followed by two steps of reverse-phase column on HPLC. The isolated inhibitor peptide was homogeneous in its N-terminal and partial amino acid sequence, showing a molecular weight of 4.489 Da by mass spectrometry and amino acid analysis. The peptide was tested with rat plasma and urine kallikrein, which resulting in an inhibition with similar afinity to both enzymes, showing an IC₅₀ of 14.3 M after 13 and 8 min, respectively, using kininogen as substrate on the isolated guinea-pig ileum bioassay. The porcine pancreatic kallikrein showed after 10 min an IC₅₀ value of 12.6 M with H-D-Val-Leu-Arg-pNA HCl as substrate. In addition, the isolated peptide significantly inhibited porcine pancreatic kallikrein with values in the range of apparent or absolute calculated peptide K _i = 2.5 M. The inhibitor was heat resistant and stable at pH values less than 5.     

Antioxidant properties of dihydroherbimycin A from a newly isolated <Emphasis Type="Italic">Streptomyces</Emphasis> sp.

During antioxidant screening using 1,1-diphenyl-picrylhydrazyl (DPPH) and a lipid peroxidation assay, a streptomycete strain was found to produce herbimycin A and dihydroherbimycin A as antioxidants in the culture filtrate. These molecules were identified by using spectral analyses, including infrared, ultraviolet, mass spectrum, and nuclear magnetic resonance assays. In the DPPH radical-scavenging assay, dihydroherbimycin A exhibited more potent antioxidant activity (IC₅₀, 1.3 μM) than α-tocopherol (IC₅₀, 2.7 μM) that was used as a reference compound. In the lipid peroxidation assay, both herbimycin A and dihydroherbimycin A demonstrated antioxidant activities of 61% and 72%, respectively, at 100 μg/ml, while α-tocopherol exhibited an activity of 93% at the same concentration. Therefore, dihydroherbimycin A might have the potential to be developed into a new therapeutic agent.     

Insecticidal action of Quinomycin A from <Emphasis Type="Italic">Streptomyces</Emphasis> sp. KN-0647, isolated from a forest soil

An actinomycete strain KN-0647 was isolated from a forest soil sample collected from Dali Cangshan mountain, Yunnan Province, China. The strain was identified as Streptomyces sp. according to the morphological, physiological characteristics and whole nucleotide sequence analysis of 16S rRNA gene, and could not be identified up to species level, just suggesting a potential new taxon. The ethyl acetate extract from this strain displayed growth inhibition on the test pathogenetic insects, such as Spodoptera exigua, Dendrolimus punctatus, Plutella xylostella, Aphis glycines and Culex pipiens. The active compound was isolated and identified through a combination of spectral and chemical methods (UR, MS, and ¹HNMR) as quinomycin A. This is the first report on the insecticidal activity of antibiotic quinomycin A.     

Purification,Characterization and Cloning of a Chymotrypsin Inhibitor (CI-9) from the Hemolymph of the Silkworm, <Emphasis Type="Italic">Bombyx mori</Emphasis>

Hemolymph chymotrypsin inhibitor 9 (CI-9) from the hemolymph of the silkworm, Bombyx mori, was purified by ammonium sulfate precipitation, Butyl Toyopearl hydrophobic chromatography, gel filtration through Sephadex C-50 and chymotrypsin-sepharose 4B affinity chromatography. Checked by Native PAGE and SDS-PAGE in combination with silver staining, the final preparation appeared homogeneous. In tricine SDS-PAGE, CI-9 displayed a molecular weight of 7.5 kD, which was determined to be 7167 Da with the Voyager TOFMass analyser. The pI value for CI-9, revealed by 2D-PAGE (two-dimensional polyacrylamide gel electrophoresis), was 4.3. CI-9 exhibited inhibitory activity at a temperature as high as 100°C and a stability against a wide range of pH (1–12). In N-terminal amino-acid analysis of CI-9, 40 amino acid residues were obtained. The C-terminal 22 amino acid residues were deduced by subsequently cloned cDNA and genomic fragments. MW and pI of CI-9 were predicted to be 7170.98 Da and 4.61, respectively, on the website. Its low molecular weight, high stability, conserved active site and Kunitz domain showed that CI-9 is a Kunitz-type CI. The difference of sequence and pI between CI-9 and other Kunitz type CIs indicated that it is a novel chymotrypsin inhibitor.